Migraine Clinical Trials in Miami, Florida

5 studies are recruiting for migraine in Miami, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

   This is a double-blind, randomized, multicenter, outpatient evaluation of the safety and efficacy of elismetrep, as compared with placebo, in the treatment of moderate or severe of migraine.

   Stage

   Phase 3

   Ages

   18 to 75

   Site

   AppleMedical Research Group, LLC, Miami, Florida

   Locations

   72 in total

   Run by

   TriGemX Bio, Inc.

   See if you can join NCT07816367 on ClinicalTrials.gov

2. Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

   This goal of this study is to compare three medications used for migraine preventive treatment. This study will compare atogepant, a newer migraine preventive medication, with two older preventive medications, topiramate and propranolol. It will be determined if one works better and is more tolerab…

   Stage

   Phase 4

   Ages

   18 to 70

   Site

   Apple Med Research, Miami, Florida

   Locations

   37 in total

   Run by

   Mayo Clinic

   See if you can join NCT06972056 on ClinicalTrials.gov

3. Study of EVO756 in Adults With Migraine

   This study will evaluate the efficacy and safety of EVO756 against placebo in adults with migraine.

   Stage

   Phase 2

   Ages

   18 to 64

   Site

   Apple Medical Research Group, Inc, Miami, Florida

   Locations

   35 in total

   Run by

   Evommune, Inc.

   See if you can join NCT07616128 on ClinicalTrials.gov

4. Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

   Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Migraine is extremely common and disabling in children. The purpose of this study is to evaluate how s…

   Stage

   Phase 3

   Ages

   6 to 17

   Site

   Columbus Clinical Services, Llc /Id# 230880, Miami, Florida

   Locations

   129 in total

   Run by

   AbbVie

   See if you can join NCT05125302 on ClinicalTrials.gov

5. Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine

   The goal of this observational study is to evaluate clinical differences in patients who received preventive treatment with medication targeting calcitonin gene-related peptide (CGRP) or its receptor: monoclonal antibodies (erenumab, galcanezumab, fremanezumab, eptinezumab) or gepants (rimegepant, …

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Miami, Miller School of Medicine, Miami, Florida

   Locations

   26 in total

   Run by

   Hospital Universitari Vall d'Hebron Research Institute

   See if you can join NCT07159750 on ClinicalTrials.gov